Matches in DBpedia 2015-10 for { ?s ?p "Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Ponezumab abstract "Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.".
- Ponezumab comment "Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.".